First Washington Corp Acadia Pharmaceuticals Inc Transaction History

First Washington Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$13.03 - $21.81 $3.45 Million - $5.77 Million	-264,760 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$15.07 - $22.34 $1.32 Million - $1.96 Million	87,810 Added 49.62%	264,760 $4.04 Million
Q1 2018 May 04, 2018	BUY	$22.47 - $32.33 $2.62 Million - $3.76 Million	116,380 Added 192.14%	176,950 $3.98 Million
Q4 2017 Feb 07, 2018	BUY	$26.84 - $39.14 $1.63 Million - $2.37 Million	60,570	60,570 $1.82 Million

370

166M

1.49M

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.83B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of First Washington Corp, based on Form 13F filings with the SEC.

Stay updated on First Washington Corp with notifications on news.